OCUL
Ocular Therapeutix, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +10.0% ·
aandelenstroom +5.5% ·
netto nieuwe posities +9.1%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | -8 | 115.87M | $1.14B | +4 | −12 |
| Q1 2026 | 101 | +4 | 114.41M | $983.07M | +11 | −8 |
| Q4 2025 | 96 | +1 | 115.21M | $1.40B | +2 | — |
| Q3 2025 | 18 | 0 | 82.57M | $965.26M | +1 | −1 |
| Q2 2025 | 15 | +1 | 57.50M | $533.65M | +1 | — |
| Q1 2025 | 11 | 0 | 20.34M | $149.08M | +1 | −1 |
| Q4 2024 | 11 | +1 | 19.58M | $167.25M | +2 | −1 |
| Q3 2024 | 9 | +1 | 15.07M | $131.15M | +1 | — |
| Q2 2024 | 8 | — | 16.30M | $111.49M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 4.46M | +4.6% | $38.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 4.46M | +4.6% | $38.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 3.60M | -4.0% | $30.74M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passief) | 3.49M | — | $29.80M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 3.24M | -1.1% | $27.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 3.24M | -1.1% | $27.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 2.94M | +43.9% | $25.07M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 638.96K | -34.6% | $5.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 638.96K | -34.6% | $5.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 447.24K | Nieuw | $3.82M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 252.94K | +21.9% | $2.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 31.42K | Nieuw | $268,318 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 26.28K | +50.3% | $224,423 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 26.28K | +50.3% | $224,423 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Millennium Management | $3.82M | 0.0% |
| D. E. Shaw & Co. | $268,318 | 0.0% |
Verlaten
| Marshall Wace | $763,365 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 266 houders, 206.22M aandelen, $1.70B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.